These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 15231572)
1. Manipulating dendritic cell biology for the active immunotherapy of cancer. O'Neill DW; Adams S; Bhardwaj N Blood; 2004 Oct; 104(8):2235-46. PubMed ID: 15231572 [TBL] [Abstract][Full Text] [Related]
2. Exploiting dendritic cells for active immunotherapy of cancer and chronic infections. O'Neill DW; Bhardwaj N Mol Biotechnol; 2007 Jun; 36(2):131-41. PubMed ID: 17914192 [TBL] [Abstract][Full Text] [Related]
3. Exploiting dendritic cells for active immunotherapy of cancer and chronic infection. O'Neill D; Bhardwaj N Methods Mol Med; 2005; 109():1-18. PubMed ID: 15585909 [TBL] [Abstract][Full Text] [Related]
4. Dendritic cells in cancer immunology and immunotherapy. Wculek SK; Cueto FJ; Mujal AM; Melero I; Krummel MF; Sancho D Nat Rev Immunol; 2020 Jan; 20(1):7-24. PubMed ID: 31467405 [TBL] [Abstract][Full Text] [Related]
5. The role of dendritic cells in cancer. Lee YS; Radford KJ Int Rev Cell Mol Biol; 2019; 348():123-178. PubMed ID: 31810552 [TBL] [Abstract][Full Text] [Related]
6. Dendritic cells: immunobiology and cancer immunotherapy. ArdavĂn C; Amigorena S; Reis e Sousa C Immunity; 2004 Jan; 20(1):17-23. PubMed ID: 14738761 [TBL] [Abstract][Full Text] [Related]
7. Dendritic cell immunobiology and potential roles in immunotherapy. Fadilah SA; Cheong SK Malays J Pathol; 2007 Jun; 29(1):1-18. PubMed ID: 19108040 [TBL] [Abstract][Full Text] [Related]
9. Optimizing dendritic cell-based immunotherapy for cancer. Zhong H; Shurin MR; Han B Expert Rev Vaccines; 2007 Jun; 6(3):333-45. PubMed ID: 17542749 [TBL] [Abstract][Full Text] [Related]
10. Tumoricidal activity of human dendritic cells. Tel J; Anguille S; Waterborg CE; Smits EL; Figdor CG; de Vries IJ Trends Immunol; 2014 Jan; 35(1):38-46. PubMed ID: 24262387 [TBL] [Abstract][Full Text] [Related]
11. Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells. Breckpot K; Heirman C; Neyns B; Thielemans K J Gene Med; 2004 Nov; 6(11):1175-88. PubMed ID: 15468193 [TBL] [Abstract][Full Text] [Related]
12. The clinical application of cancer immunotherapy based on naturally circulating dendritic cells. Bol KF; Schreibelt G; Rabold K; Wculek SK; Schwarze JK; Dzionek A; Teijeira A; Kandalaft LE; Romero P; Coukos G; Neyns B; Sancho D; Melero I; de Vries IJM J Immunother Cancer; 2019 Apr; 7(1):109. PubMed ID: 30999964 [TBL] [Abstract][Full Text] [Related]
13. Dendritic cells in cancer vaccines. Brossart P; Wirths S; Brugger W; Kanz L Exp Hematol; 2001 Nov; 29(11):1247-55. PubMed ID: 11698120 [TBL] [Abstract][Full Text] [Related]
14. Day 3 Poly (I:C)-activated dendritic cells generated in CellGro for use in cancer immunotherapy trials are fully comparable to standard Day 5 DCs. Truxova I; Pokorna K; Kloudova K; Partlova S; Spisek R; Fucikova J Immunol Lett; 2014 Jul; 160(1):39-49. PubMed ID: 24726860 [TBL] [Abstract][Full Text] [Related]